Literature DB >> 20188409

Lymphadenectomy in endometrial cancer: when, not if.

Sean C Dowdy1, Andrea Mariani.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20188409     DOI： 10.1016/S0140-6736(09)62068-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer.

Authors:  N Bharwani; M E Miquel; A Sahdev; P Narayanan; G Malietzis; R H Reznek; A G Rockall
Journal:  Br J Radiol       Date:  2011-09-06       Impact factor: 3.039

2.  Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm.

Authors:  Francesco Multinu; Jennifer A Ducie; Ane Gerda Zahl Eriksson; Brooke A Schlappe; William A Cliby; Gretchen E Glaser; Tommaso Grassi; Gary L Keeney; Amy L Weaver; Nadeem R Abu-Rustum; Mario M Leitao; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2019-10-08       Impact factor: 5.482

3.  The role of frozen section in surgical staging of low risk endometrial cancer.

Authors:  Sanjeev Kumar; Sudeshna Bandyopadhyay; Assaad Semaan; Jay P Shah; Haider Mahdi; Robert Morris; Adnan Munkarah; Rouba Ali-Fehmi
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

4.  Imaging of endometrial and cervical cancer.

Authors:  Shilpa Patel; Sidath H Liyanage; Anju Sahdev; Andrea G Rockall; Rodney H Reznek
Journal:  Insights Imaging       Date:  2010-09-28

5.  Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).

Authors:  Jen-Ruei Chen; Ting-Chang Chang; Hung-Chun Fu; Hei-Yu Lau; I-Hui Chen; Yu-Min Ke; Yu-Ling Liang; An-Jen Chiang; Chia-Yen Huang; Yu-Chieh Chen; Mun-Kun Hong; Yu-Chi Wang; Kuo-Feng Huang; Sheng-Mou Hsiao; Peng-Hui Wang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.